Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Biorxiv : the Preprint Server for Biology|February 27, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancerXin Cheng, Changli Qian, Erica Holdridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2019
Genomic Evolutionary Patterns of Leiomyosarcoma and LiposarcomaAli Amin-Mansour, Suzanne George, Stefano Sioletic, et al.
The American Journal of Surgical Pathology|September 18, 2012
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangementCheng-Han Lee, Rola H Ali, Marjan Rouzbahman, et al.
Nature Communications|May 4, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancerXin Cheng, Yadong Zhang, Changli Qian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 12, 2026
The Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable MutationsMerve Kaya, Lawrence H Lin, Jan Oosting, et al.
The Journal of Pathology|September 11, 2015
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic typeAnthony N Karnezis, Yemin Wang, Pilar Ramos, et al.
JAMA Oncology|July 28, 2022
Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial CancerPanagiotis A Konstantinopoulos, Allison A Gockley, Niya Xiong, et al.
Cancer Discovery|September 15, 2018
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer OrganoidsSarah J Hill, Brennan Decker, Emma A Roberts, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 22, 2017
Interobserver Reproducibility Among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract CarcinosarcomasAnkur R Sangoi, Malti Kshirsagar, Andres A Roma, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 12, 2018
Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC)Helena M Ditzel, Kyle C Strickland, Emily E Meserve, et al.
Pageof 18